AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJuly 1st, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 1, 2021 (the “Effective Date”), between Diane Young, MD (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).